Journal of Clinical Pathways May 5, 2022
Sara Ratner, Icario

In this commentary, Sara Ratner, senior vice president, government markets and strategic initiatives, Icario, reviews requirements health plans should be aware of under CMS’ recently issued 2023 Final Rule.

On April 29, 2022, the Centers for Medicare & Medicaid Services (CMS) released the Contract Year (CY) 2023 Medicare Advantage and Part D Final Rule.

While the final rule is consistent with the January 2022 proposed rule, the changes represent a shift in CMS policy with an increased focus on alignment and coordination for dual eligibles and a commitment to addressing the increases in beneficiary cost-sharing and improved consumer protections through new regulation.

The following details the significant provisions and potential impact.

Improved Experience for Dual Eligibles

Through this final...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: CMS, Govt Agencies, Insurance, Medicare Advantage, Patient / Consumer, Provider
Where US hospitals stand on value of heart attack care: 5 things to know
ACA enrollment breaks records again in 2025
Getting ready for the new Five-Star ratings
CMS issues flurry of Medicare fines to payers
ACP expresses support for proposed Medicare $2 Drug List Model

Share This Article